InnoCare Optoelectronics (6861) Q1 2026 earnings summary

Executive summary

• Revenue for Q2 115 was NT$757,027K, up 37% year-over-year; net income for the quarter was NT$96,745K, up 202% year-over-year.

• Gross margin for Q2 115 remained stable at 29% compared to the prior year.

• Basic EPS for Q2 115 was NT$2.33, up from NT$0.77 in Q2 114.

Financial highlights

• Six-month revenue reached NT$1,548,068K, a 42% increase year-over-year.

• Six-month net income was NT$184,757K, up 147% year-over-year.

• Operating income for the first half was NT$182,891K, up from NT$74,133K year-over-year.

• Cash and equivalents at June 30, 115 were NT$867,461K.

• Total assets at June 30, 115 were NT$2,977,754K; equity was NT$1,557,899K.

Outlook and guidance

• The company expects no material impact from new IFRS standards until at least 2027.

• No early adoption of IFRS 18 and related amendments is planned.